Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Jewish researcher shares Nobel Prize in medicine for identifying Hepatitis C virus

(JTA) — The Nobel Prize in medicine was awarded to three scientists who identified the hepatitis C virus.

The prize was awarded Monday to Harvey Alter of the National Institutes of Health, Michael Houghton of the University of Alberta, and Charles Rice of Rockefeller University.

“The Nobel Laureates’ discovery of Hepatitis C virus is a landmark achievement in the ongoing battle against viral diseases. Thanks to their discovery, highly sensitive blood tests for the virus are now available and these have essentially eliminated post-transfusion hepatitis in many parts of the world, greatly improving global health,” the Nobel committee said in announcing the prize.

Alter, 85, who is Jewish, was born in New York and attended medical school at the University of Rochester. Early in his career he worked with the Nobel Prize-winning scientist Baruch Blumberg, who identified the hepatitis B virus.

In 2000, he received the Albert Lasker Award for Clinical Medical Research for his work leading to the discovery of the virus that causes hepatitis C.

Houghton isolated the genetic sequence of the new hepatitis C virus while working at Chiron Corporation in the 1980s. Rice showed that hepatitis C virus alone could cause hepatitis.

The post Jewish researcher shares Nobel Prize in medicine for identifying hepatitis C virus appeared first on Jewish Telegraphic Agency.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.